The aftershocks of the boardroom coup rippled through LX Group with seismic force. Director Park's suspension was the headline, but the real tremor was the unsealing of Jin-woo's report. Ha-ru, true to his word, had it published on the company's main portal, stripped of legalese, a raw and damning indictment. The stock plummeted, then stabilized, then began a slow, curious climb as ethical investment funds took note. The media cycle was brutal, but it was a clean brutality—LX was taking its medicine publicly, and Chairman Kang was the uncompromising physician forcing it down.
